Oxytocin receptor single nucleotide polymorphism predicts atony-related postpartum hemorrhage

Elise N. Erickson,Kathleen M. Krol,Allison M. Perkeybile,Jessica J. Connelly,Leslie Myatt
DOI: https://doi.org/10.1186/s12884-022-05205-w
2022-11-30
BMC Pregnancy and Childbirth
Abstract:Postpartum hemorrhage remains a key contributor to overall maternal morbidity in the United States. Current clinical assessment methods used to predict postpartum hemorrhage are unable to prospectively identify about 40% of hemorrhage cases. Oxytocin is a first-line pharmaceutical for preventing and treating postpartum hemorrhage, which acts through oxytocin receptors on uterine myocytes. Existing research indicates that oxytocin function is subject to variation, influenced in part by differences in the DNA sequence within the oxytocin receptor gene. One variant, rs53576, has been shown to be associated with variable responses to exogenous oxytocin when administered during psychological research studies. How this variant may influence myometrial oxytocin response in the setting of third stage labor has not been studied. We tested for differences in the frequency of the oxytocin receptor genotype at rs53576 in relationship to the severity of blood loss among a sample of individuals who experienced vaginal birth.
obstetrics & gynecology
What problem does this paper attempt to address?